Skip to main content
SpringerLink
Log in

Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis

  • Correspondence
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

No datasets were generated or analysed during the current study.

References

  1. Arora H, Mammi M, Patel NM, et al (2023) Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis. J Neurooncol https://doi.org/10.1007/s11060-023-04549-3

  2. Arvold ND, Armstrong TS, Warren KE, et al (2018) Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group. Neuro Oncol 20(7):897–906. https://doi.org/10.1093/neuonc/noy056

  3. Zhou L, Shen Y, Huang T, et al (2021) The Prognostic Effect of Dexamethasone on Patients With Glioblastoma: A Systematic Review and Meta-Analysis. Front Pharmacol 12:727707. Published 2021 Aug 31. https://doi.org/10.3389/fphar.2021.727707

Download references

Author information

Authors and Affiliations

  1. College of Medicine, Drexel University, Philadelphia, PA, USA

    Peter G. Zaki & Sanjeev Herr

  2. Department of Neurosurgery, Allegheny General Hospital, 320 East North Avenue, 15212, Pittsburgh, PA, USA

    Matthew J. Shepard

Authors
  1. Peter G. Zaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanjeev Herr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthew J. Shepard
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors have contributed equally to the composition of this manuscript and all authors reviewed it.

Corresponding author

Correspondence to Matthew J. Shepard.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zaki, P.G., Herr, S. & Shepard, M.J. Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis. J Neurooncol 167, 363–364 (2024). https://doi.org/10.1007/s11060-024-04602-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-024-04602-9

Search

Navigation